Bridging a pharma-like innovation gap in medical nutrition.

Tamar Weenen, KDS (Kenneth) Fernald, Esther Pronker, Harry Commandeur, Eric Claassen

Research output: Chapter/Conference proceedingChapterAcademic

2 Citations (Scopus)


This chapter focuses on the current and possible future development scenarios for the medical nutrition industry. It starts off by exploring the definitions and characteristics of the pharmanutrition industries in the European health and life science sector. By taking conventional foods at one end of the spectrum, and pharmaceutical products at the other, the pharmanutrition industry can be split further into two categories falling within this spectrum: functional foods and medical nutrition. Section two exemplifies the developmental trends of the medical nutrition industry. Various industry life cycle scenarios are defined in order to forecast the direction in which this pharmanutrition industry could mature. Concepts such as the innovation cliff and jumping the S-curve are described, and strategies to overcome common bottlenecks are proposed. The last section describes patenting behaviour in the medical nutrition industry, offering a patent decision framework for intellectual property protection strategies. The chapter rounds off with a general discussion as to the successful future development of the medical nutrition industry. Add to Papers Other actions About this Book Reprints and Permissions Share
Original languageEnglish
Title of host publicationAdvances in Pharmaceutical Sciences
EditorsD.J. Crommelin, R.A. Lipper
Place of PublicationBerlin
Number of pages24
ISBN (Print)9783319061504
Publication statusPublished - 2014

Publication series

SeriesSpringer Book Series

Research programs

  • EUR ESE 34
  • EMC MM-04-27-01


Dive into the research topics of 'Bridging a pharma-like innovation gap in medical nutrition.'. Together they form a unique fingerprint.

Cite this